Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
BMJ Open
|
May 29, 2020
Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
Shaista Hafeez, Emma Patel, Amanda Webster, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 18, 2018
Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer
Alison Claire Tree, Kelly Jones, Shaista Hafeez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 28, 2024
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer
Amanda Webster, Michael Francis, Hannah Gribble, et al.
Clinical and Translational Radiation Oncology
|
August 8, 2019
Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module
Emma Patel, Yat Tsang, Angela Baker, et al.
Frontiers in Oncology
|
March 15, 2021
MR-Guided Adaptive Radiotherapy for Bladder Cancer
Adham Hijab, Boris Tocco, Ian Hanson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2015
The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer
Anne Vestergaard, Shaista Hafeez, Ludvig P Muren, et al.
Frontiers in Oncology
|
December 1, 2022
Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy
Shaista Hafeez, Mu Koh, Kelly Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment
Shaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
October 27, 2025
Evaluating participant experiences and tolerability with MR Linac imaging
Jayde Nartey, Helen A McNair, Katie Biscombe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy
Rosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
BMJ Open
|
May 29, 2020
Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
Shaista Hafeez, Emma Patel, Amanda Webster, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 18, 2018
Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer
Alison Claire Tree, Kelly Jones, Shaista Hafeez, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 28, 2024
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer
Amanda Webster, Michael Francis, Hannah Gribble, et al.
Clinical and Translational Radiation Oncology
|
August 8, 2019
Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module
Emma Patel, Yat Tsang, Angela Baker, et al.
Frontiers in Oncology
|
March 15, 2021
MR-Guided Adaptive Radiotherapy for Bladder Cancer
Adham Hijab, Boris Tocco, Ian Hanson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2015
The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer
Anne Vestergaard, Shaista Hafeez, Ludvig P Muren, et al.
Frontiers in Oncology
|
December 1, 2022
Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy
Shaista Hafeez, Mu Koh, Kelly Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment
Shaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
October 27, 2025
Evaluating participant experiences and tolerability with MR Linac imaging
Jayde Nartey, Helen A McNair, Katie Biscombe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 30, 2023
Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy
Rosalyne Laura Westley, Katie Biscombe, Alex Dunlop, et al.
Page
of 4